Sexually Transmitted Infection (STI) Testing — Nucleic Acid (DNA/RNA) Reimbursement
This document governs reimbursement and coding rules for nucleic acid (DNA/RNA) sexually transmitted infection (STI) testing for Oscar Health providers, describing when single-test CPT codes are bundled into a comprehensive panel and how claims will be adjudicated.
No material clinical or coverage changes in this revision.
Coverage and Claim Adjudication Rules
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.